| 1 |
31397978 | Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis. | 2019 Oct |
4 |
| 2 |
27105508 | Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo. | 2016 May 31 |
5 |
| 3 |
21514634 | Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma. | 2011 Jul |
1 |
| 4 |
19686789 | Development of a highly stable and targetable nanoliposomal formulation of topotecan. | 2010 Jan 4 |
1 |
| 5 |
15923621 | DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation. | 2005 Jun |
5 |
| 6 |
11410862 | Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. | 2001 Jul 15 |
1 |
| 7 |
11459199 | Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines. | 2001 Jun |
2 |